315 related articles for article (PubMed ID: 32629172)
21. Protein arginine methylation: Cellular functions and methods of analysis.
Pahlich S; Zakaryan RP; Gehring H
Biochim Biophys Acta; 2006 Dec; 1764(12):1890-903. PubMed ID: 17010682
[TBL] [Abstract][Full Text] [Related]
22. Intricate Effects of α-Amino and Lysine Modifications on Arginine Methylation of the N-Terminal Tail of Histone H4.
Fulton MD; Zhang J; He M; Ho MC; Zheng YG
Biochemistry; 2017 Jul; 56(28):3539-3548. PubMed ID: 28644004
[TBL] [Abstract][Full Text] [Related]
23. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
24. Protein arginine methyltransferases interact with intraflagellar transport particles and change location during flagellar growth and resorption.
Mizuno K; Sloboda RD
Mol Biol Cell; 2017 May; 28(9):1208-1222. PubMed ID: 28298486
[TBL] [Abstract][Full Text] [Related]
25. Protein arginine methyltransferases (PRMTs): role in chromatin organization.
Jahan S; Davie JR
Adv Biol Regul; 2015 Jan; 57():173-84. PubMed ID: 25263650
[TBL] [Abstract][Full Text] [Related]
26. Cancer synthetic vulnerabilities to protein arginine methyltransferase inhibitors.
Guccione E; Schwarz M; Di Tullio F; Mzoughi S
Curr Opin Pharmacol; 2021 Aug; 59():33-42. PubMed ID: 34052526
[TBL] [Abstract][Full Text] [Related]
27. Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach.
Iannelli G; Milite C; Marechal N; Cura V; Bonnefond L; Troffer-Charlier N; Feoli A; Rescigno D; Wang Y; Cipriano A; Viviano M; Bedford MT; Cavarelli J; Castellano S; Sbardella G
J Med Chem; 2022 Sep; 65(17):11574-11606. PubMed ID: 35482954
[TBL] [Abstract][Full Text] [Related]
28. The role of protein arginine methyltransferases in kidney diseases.
Zhang C; Zhuang S
Clin Sci (Lond); 2020 Aug; 134(15):2037-2051. PubMed ID: 32766778
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms and Inhibitors of Histone Arginine Methylation.
Fulton MD; Brown T; Zheng YG
Chem Rec; 2018 Dec; 18(12):1792-1807. PubMed ID: 30230223
[TBL] [Abstract][Full Text] [Related]
30. Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies.
Bryant JP; Heiss J; Banasavadi-Siddegowda YK
Cells; 2021 Jan; 10(1):. PubMed ID: 33440687
[TBL] [Abstract][Full Text] [Related]
31. Protein arginine methyltransferases in protozoan parasites.
Rodriguez MA
Parasitology; 2022 Apr; 149(4):427-435. PubMed ID: 35331350
[TBL] [Abstract][Full Text] [Related]
32. Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).
Morales Y; Cáceres T; May K; Hevel JM
Arch Biochem Biophys; 2016 Jan; 590():138-152. PubMed ID: 26612103
[TBL] [Abstract][Full Text] [Related]
33. Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy.
Dai W; Zhang J; Li S; He F; Liu Q; Gong J; Yang Z; Gong Y; Tang F; Wang Z; Xie C
Front Immunol; 2022; 13():865964. PubMed ID: 35493527
[TBL] [Abstract][Full Text] [Related]
34. Protein arginine methyltransferases (PRMTs) as therapeutic targets.
Cha B; Jho EH
Expert Opin Ther Targets; 2012 Jul; 16(7):651-64. PubMed ID: 22621686
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of asymmetric arginine methylation during replicative and H2O2-induced premature senescence in WI-38 human diploid fibroblasts.
Lim Y; Lee E; Lee J; Oh S; Kim S
J Biochem; 2008 Oct; 144(4):523-9. PubMed ID: 18676353
[TBL] [Abstract][Full Text] [Related]
36. Toward Understanding Molecular Recognition between PRMTs and their Substrates.
Price OM; Hevel JM
Curr Protein Pept Sci; 2020; 21(7):713-724. PubMed ID: 31976831
[TBL] [Abstract][Full Text] [Related]
37. The role of arginine methylation in the DNA damage response.
Auclair Y; Richard S
DNA Repair (Amst); 2013 Jul; 12(7):459-65. PubMed ID: 23684798
[TBL] [Abstract][Full Text] [Related]
38. Protein arginine methylation in estrogen signaling and estrogen-related cancers.
Teyssier C; Le Romancer M; Sentis S; Jalaguier S; Corbo L; Cavaillès V
Trends Endocrinol Metab; 2010 Mar; 21(3):181-9. PubMed ID: 20005732
[TBL] [Abstract][Full Text] [Related]
39. PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity.
Goel PN; Grover P; Greene MI
Crit Rev Immunol; 2020; 40(4):283-295. PubMed ID: 33426818
[TBL] [Abstract][Full Text] [Related]
40. An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022).
Dong J; Duan J; Hui Z; Garrido C; Deng Z; Xie T; Ye XY
Expert Opin Ther Pat; 2022 Dec; 32(12):1185-1205. PubMed ID: 36594709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
